{"id":5215,"date":"2026-03-02T09:00:00","date_gmt":"2026-03-02T06:00:00","guid":{"rendered":""},"modified":"2026-03-02T09:00:00","modified_gmt":"2026-03-02T06:00:00","slug":"gizlilik-politikasi","status":"publish","type":"post","link":"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/","title":{"rendered":"Cinsiyet Se\u00e7imi \u0130\u00e7in PGD: Uluslararas\u0131 Hastalar Neler Bilmeli"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_84 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u0130\u00e7indekiler<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"\u0130\u00e7indekiler Tablosunu A\u00e7\/Kapat\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">A\u00e7\/kapa<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Understanding_PGD_for_Gender_Selection\" >Cinsiyet Se\u00e7imi i\u00e7in PGD'yi Anlamak<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#How_Does_PGD_for_Gender_Selection_Work\" >Cinsiyet Se\u00e7imi \u0130\u00e7in PGD Nas\u0131l \u00c7al\u0131\u015f\u0131r?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Step_1_IVF_Stimulation_and_Egg_Retrieval\" >Ad\u0131m 1: Yumurta Geli\u015ftirme ve Toplama<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Step_2_Embryo_Biopsy\" >Ad\u0131m 2: Embriyo Biyopsisi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Step_3_Genetic_Analysis\" >3. Ad\u0131m: Genetik Analiz<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Step_4_Embryo_Selection_and_Transfer\" >Ad\u0131m 4: Embriyo Se\u00e7imi ve Transferi<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Accuracy_of_PGD_for_Gender_Selection\" >Cinsiyet Se\u00e7imi \u0130\u00e7in PGD'nin Do\u011frulu\u011fu<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Who_Seeks_PGD_for_Gender_Selection\" >Cinsiyet Se\u00e7imi \u0130\u00e7in PGD'yi Kimler Talep Eder?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Medical_Indications\" >T\u0131bbi Endikasyonlar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Family_Balancing\" >Aile Dengesi<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Why_Choose_Cyprus_for_PGD_Gender_Selection\" >Neden Cinsiyet Se\u00e7imi \u0130\u00e7in K\u0131br\u0131s'\u0131 Tercih Etmelisiniz?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Legal_Framework\" >Yasal \u00c7er\u00e7eve<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Compared_to_Other_Destinations\" >Di\u011fer Destinasyonlarla Kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#No_Waiting_Lists\" >Bekleme Listesi Yok<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#The_Role_of_PGT-A_in_Gender_Selection_Cycles\" >Cinsiyet Se\u00e7im D\u00f6ng\u00fclerinde PGT-A'n\u0131n Rol\u00fc<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Success_Rates_for_PGD_Gender_Selection_Cycles\" >PGD Cinsiyet Se\u00e7imi D\u00f6ng\u00fclerinde Ba\u015far\u0131 Oranlar\u0131<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Ethical_Considerations\" >Etik Hususlar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#What_International_Patients_Should_Prepare\" >Uluslararas\u0131 Hastalar\u0131n Haz\u0131rlamas\u0131 Gerekenler<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Initial_Consultation\" >\u0130lk Dan\u0131\u015fma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Treatment_Timeline\" >Tedavi Zaman \u00c7izelgesi<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Required_Documents_and_Tests\" >Gerekli Belgeler ve Testler<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Combining_PGD_with_Other_Services\" >PGD'yi Di\u011fer Hizmetlerle Birle\u015ftirmek<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/gynolifeivf.com\/tr\/gizlilik-politikasi\/#Begin_Your_Family_Balancing_Journey\" >Aile Denge Yolculu\u011funuza Ba\u015flay\u0131n<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Understanding_PGD_for_Gender_Selection\"><\/span>Cinsiyet Se\u00e7imi i\u00e7in PGD'yi Anlamak<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Preimplantasyon Genetik Tan\u0131 (PGT)<\/strong> tedavi d\u00f6ng\u00fcs\u00fc s\u0131ras\u0131nda embriyolar\u0131n rahme transfer edilmeden \u00f6nce genetik olarak test edilmesini sa\u011flayan geli\u015fmi\u015f bir \u00fcreme teknolojisidir. PGD ba\u015flang\u0131\u00e7ta ciddi genetik hastal\u0131klar\u0131 taramak i\u00e7in geli\u015ftirilmi\u015f olsa da, embriyo cinsiyetinin de neredeyse hatas\u0131z bir do\u011frulukla belirlenmesini sa\u011flar. Bir\u00e7ok uluslararas\u0131 hasta i\u00e7in, <a href=\"\/tr\/hizmet\/preimplantasyon-genetik-tani-pgd\/\">Cinsiyet se\u00e7imi i\u00e7in PGD<\/a> K\u0131br\u0131s'ta aile dengesi amac\u0131yla, g\u00fcvenli, yasal ve t\u0131bbi g\u00f6zetim alt\u0131nda bir ortamda \u00e7ocuklar\u0131n\u0131n cinsiyetini se\u00e7mek i\u00e7in e\u015fsiz bir f\u0131rsat sunulmaktad\u0131r.<\/p>\n<p>At <strong>GynoLife IVF Center<\/strong>, Biz hem t\u0131bbi hem de aile dengesi endikasyonlar\u0131 i\u00e7in kapsaml\u0131 PGD hizmetleri sunmaktay\u0131z. Bu rehber, uluslararas\u0131 hastalar\u0131n s\u00fcre\u00e7 hakk\u0131nda bilmesi gereken her \u015feyi, nas\u0131l \u00e7al\u0131\u015ft\u0131\u011f\u0131, kimlerin faydalanabilece\u011fi, yasal hususlar ve tedavi s\u0131ras\u0131nda nelerin beklenece\u011fi dahil olmak \u00fczere a\u00e7\u0131klamaktad\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Does_PGD_for_Gender_Selection_Work\"><\/span>Cinsiyet Se\u00e7imi \u0130\u00e7in PGD Nas\u0131l \u00c7al\u0131\u015f\u0131r?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cinsiyet se\u00e7imi i\u00e7in PGD, bir IVF d\u00f6ng\u00fcs\u00fcn\u00fcn par\u00e7as\u0131 olarak ger\u00e7ekle\u015ftirilir. S\u00fcre\u00e7, her biri \u00f6zel uzmanl\u0131k ve ileri laboratuvar teknolojisi gerektiren, hassas bir \u015fekilde koordine edilmi\u015f birka\u00e7 ad\u0131mdan olu\u015fur.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_1_IVF_Stimulation_and_Egg_Retrieval\"><\/span>Ad\u0131m 1: Yumurta Geli\u015ftirme ve Toplama<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>S\u00fcre\u00e7 standart bir t\u00fcp bebek d\u00f6ng\u00fcs\u00fc ile ba\u015flar. Kad\u0131n hasta, \u00e7ok say\u0131da yumurta \u00fcretmek i\u00e7in kontroll\u00fc yumurtal\u0131k uyar\u0131lmas\u0131na tabi tutulur ve bu yumurtalar daha sonra k\u00fc\u00e7\u00fck bir cerrahi i\u015flemle al\u0131n\u0131r. Bu yumurtalar laboratuvarda sperm ile, ya geleneksel t\u00fcp bebek ya da ICSI yoluyla d\u00f6llenerek embriyo olu\u015fturulur.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_2_Embryo_Biopsy\"><\/span>Ad\u0131m 2: Embriyo Biyopsisi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Embriyolar blastokist evresine ula\u015ft\u0131\u011f\u0131nda, genellikle geli\u015fimlerinin be\u015finci veya alt\u0131nc\u0131 g\u00fcn\u00fcnde, trophehtodermden, yani plasentay\u0131 olu\u015fturacak olan embriyonun d\u0131\u015f tabakas\u0131ndan az say\u0131da h\u00fccre dikkatlice al\u0131n\u0131r. Bu biyopsi embriyoya zarar vermez veya geli\u015fimsel potansiyelini etkilemez. Biyopsi yap\u0131lan h\u00fccreler genetik analiz i\u00e7in g\u00f6nderilirken embriyolar vitrifikasyon i\u015flemine tabi tutularak g\u00fcvenli bir \u015fekilde saklan\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_3_Genetic_Analysis\"><\/span>3. Ad\u0131m: Genetik Analiz<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Biyopsi \u00f6rne\u011fi al\u0131nan h\u00fccreler, yeni nesil dizileme (NGS) veya dizi kar\u015f\u0131la\u015ft\u0131rmal\u0131 genomik hibritizasyon (aCGH) gibi geli\u015fmi\u015f genetik test teknolojileri kullan\u0131larak analiz edilir. Bu testler, cinsiyet kromozomlar\u0131 da dahil olmak \u00fczere her embriyonun kromozomal yap\u0131s\u0131n\u0131 inceler. XX kromozomlar\u0131na sahip embriyolar di\u015fi, XY kromozomlar\u0131na sahip olanlar ise erkektir. Testler, kromozomal anormallikleri de tespit ederek her embriyo hakk\u0131nda kapsaml\u0131 genetik bilgi sa\u011flar.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Step_4_Embryo_Selection_and_Transfer\"><\/span>Ad\u0131m 4: Embriyo Se\u00e7imi ve Transferi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Genetik sonu\u00e7lar genellikle bir ila iki hafta i\u00e7inde haz\u0131r oldu\u011funda, hasta istenen cinsiyet ve kromozomal normale g\u00f6re hangi embriyoya transfer yapaca\u011f\u0131na karar verir. Se\u00e7ilen embriyo \u00e7\u00f6z\u00fcl\u00fcr ve dondurulmu\u015f embriyo transfer d\u00f6ng\u00fcs\u00fcnde rahme yerle\u015ftirilir. Sadece istenen cinste kromozomal olarak normal embriyolar transfer edilir, bu da sa\u011fl\u0131kl\u0131 bir gebelik \u015fans\u0131n\u0131 ve cinsiyet se\u00e7iminin do\u011frulu\u011funu en \u00fcst d\u00fczeye \u00e7\u0131kar\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Accuracy_of_PGD_for_Gender_Selection\"><\/span>Cinsiyet Se\u00e7imi \u0130\u00e7in PGD'nin Do\u011frulu\u011fu<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>PGD, ,9'un \u00fczerinde do\u011fruluk oranlar\u0131yla cinsiyet se\u00e7imi i\u00e7in mevcut en do\u011fru y\u00f6ntemdir. Diyet de\u011fi\u015fiklikleri, cinsel ili\u015fki zamanlamas\u0131 veya sperm ay\u0131rma teknikleri gibi bebe\u011fin cinsiyetini etkiledi\u011fini iddia eden di\u011fer y\u00f6ntemlerin aksine, PGD her embriyonun genetik yap\u0131s\u0131n\u0131 do\u011frudan inceleyerek neredeyse hi\u00e7 hata pay\u0131 b\u0131rakmaz.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Who_Seeks_PGD_for_Gender_Selection\"><\/span>Cinsiyet Se\u00e7imi \u0130\u00e7in PGD'yi Kimler Talep Eder?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cinsiyet se\u00e7imi i\u00e7in PGD yapt\u0131ran hastalar genellikle iki kategoriye ayr\u0131l\u0131r: t\u0131bbi endikasyonlar\u0131 olanlar ve aile dengesini arayanlar.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Medical_Indications\"><\/span>T\u0131bbi Endikasyonlar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Baz\u0131 genetik rahats\u0131zl\u0131klar cinsiyete ba\u011fl\u0131d\u0131r, bu da ba\u015fl\u0131ca bir cinsiyeti etkiledikleri anlam\u0131na gelir. Hemofili, Duchenne kas distrofisi ve belirli renk k\u00f6rl\u00fc\u011f\u00fc t\u00fcrleri buna \u00f6rnektir. Bu rahats\u0131zl\u0131klar\u0131 ta\u015f\u0131yan aileler i\u00e7in PGD, etkilenmemi\u015f cinsiyetteki embriyolar\u0131 se\u00e7melerine olanak tan\u0131yarak rahats\u0131zl\u0131\u011f\u0131 \u00e7ocuklar\u0131na ge\u00e7irme riskini \u00f6nemli \u00f6l\u00e7\u00fcde azalt\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Family_Balancing\"><\/span>Aile Dengesi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Bir\u00e7ok hasta, aile dengesi amac\u0131yla cinsiyet se\u00e7imi talep etmektedir; bu, mevcut \u00e7ocuklar\u0131n\u0131n bir veya daha fazlas\u0131n\u0131n bir cinsiyetten olmas\u0131 ve daha dengeli bir aile olu\u015fturmak i\u00e7in di\u011fer cinsiyetten bir \u00e7ocu\u011fa sahip olma iste\u011fi anlam\u0131na gelir. Bu durum, \u00f6zellikle ayn\u0131 cinsiyetten birden fazla \u00e7ocu\u011fa sahip olan ve di\u011fer cinsiyetten bir \u00e7ocu\u011fu b\u00fcy\u00fctme deneyimini kuvvetle arzulayan hastalarda yayg\u0131nd\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Choose_Cyprus_for_PGD_Gender_Selection\"><\/span>Neden Cinsiyet Se\u00e7imi \u0130\u00e7in K\u0131br\u0131s'\u0131 Tercih Etmelisiniz?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>K\u0131br\u0131s, yasal eri\u015filebilirli\u011fin, t\u0131bbi uzmanl\u0131\u011f\u0131n ve uygun maliyetin birle\u015fimiyle uluslararas\u0131 hastalar i\u00e7in ideal bir se\u00e7enek haline gelmesiyle, PGD cinsiyet se\u00e7imi i\u00e7in en pop\u00fcler destinasyonlardan biri haline geldi.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Legal_Framework\"><\/span>Yasal \u00c7er\u00e7eve<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Avrupa'da ve d\u00fcnya genelinde bir\u00e7ok \u00fclke medikal olmayan nedenlerle cinsiyet se\u00e7imi uygulamalar\u0131n\u0131 k\u0131s\u0131tlarken veya yasaklarken, K\u0131br\u0131s, t\u0131bbi genetik tan\u0131 (PGD) ile aile dengesi amac\u0131yla cinsiyet se\u00e7imine izin vermektedir. Bu yasal ortam, hastalar\u0131n \u015feffaf ve profesyonel denetim alt\u0131nda, d\u00fczenlenmi\u015f ve t\u0131bbi g\u00f6zetim alt\u0131nda cinsiyet se\u00e7imi yapmalar\u0131na olanak tan\u0131maktad\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Compared_to_Other_Destinations\"><\/span>Di\u011fer Destinasyonlarla Kar\u015f\u0131la\u015ft\u0131r\u0131ld\u0131\u011f\u0131nda<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Cinsiyet se\u00e7imi d\u00fc\u015f\u00fcnen hastalar genellikle K\u0131br\u0131s'\u0131 Amerika Birle\u015fik Devletleri, Tayland ve Meksika gibi di\u011fer \u00fclkelerle kar\u015f\u0131la\u015ft\u0131r\u0131r. Amerika Birle\u015fik Devletleri de cinsiyet se\u00e7imine izin verirken, tedavi maliyetleri \u00f6nemli \u00f6l\u00e7\u00fcde daha y\u00fcksektir, genellikle K\u0131br\u0131s'taki tedavinin iki ila \u00fc\u00e7 kat\u0131 kadar. K\u0131br\u0131s, Avrupa t\u0131bbi standartlar\u0131, yasal netlik ve e\u015fle\u015ftirmesi zor uygun fiyat\u0131n cazip bir kombinasyonunu sunar.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"No_Waiting_Lists\"><\/span>Bekleme Listesi Yok<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Baz\u0131 pop\u00fcler t\u00fcp bebek turizmi destinasyonlar\u0131n\u0131n aksine, K\u0131br\u0131s'taki GynoLife IVF Center gibi klinikler genellikle daha k\u0131sa bekleme s\u00fcrelerine sahiptir, bu da hastalar\u0131n daha h\u0131zl\u0131 tedaviye ba\u015flamalar\u0131na olanak tan\u0131r. Bu, \u00f6zellikle ya\u015fa ba\u011fl\u0131 t\u00fcp bebek kayg\u0131lar\u0131yla ba\u015fa \u00e7\u0131kan hastalar i\u00e7in \u00f6nemlidir.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"The_Role_of_PGT-A_in_Gender_Selection_Cycles\"><\/span>Cinsiyet Se\u00e7im D\u00f6ng\u00fclerinde PGT-A'n\u0131n Rol\u00fc<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cinsiyet se\u00e7imi i\u00e7in PGD, genellikle kromozomal anormallikler a\u00e7\u0131s\u0131ndan embriyolar\u0131 tarayan PGT-A (An\u00f6ploidiler \u0130\u00e7in \u0130mplantasyon \u00d6ncesi Genetik Tan\u0131) ile birle\u015ftirilir. Bu kombinasyon birden fazla fayda sa\u011flar: her embriyonun cinsiyetini belirler, se\u00e7ilen embriyolar\u0131n do\u011fru say\u0131da kromozoma sahip oldu\u011funu do\u011frular, kromozomal olarak anormal embriyolar\u0131n transferini engelleyerek d\u00fc\u015f\u00fck riskini azalt\u0131r ve genel IVF ba\u015far\u0131 oranlar\u0131n\u0131 iyile\u015ftirir.<\/p>\n<p>GynoLife IVF Merkezi'nde, t\u00fcm PGD cinsiyet belirleme d\u00f6ng\u00fcleri i\u00e7in kapsaml\u0131 kromozomal tarama \u00f6neriyoruz. Bu entegre yakla\u015f\u0131m, transfer i\u00e7in se\u00e7ilen embriyonun sadece istenen cinsiyette de\u011fil, ayn\u0131 zamanda kromozomal olarak sa\u011fl\u0131kl\u0131 olmas\u0131n\u0131 sa\u011flayarak hastalara ba\u015far\u0131l\u0131 bir gebelik ve sa\u011fl\u0131kl\u0131 bir bebek i\u00e7in m\u00fcmk\u00fcn olan en iyi \u015fans\u0131 verir.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Success_Rates_for_PGD_Gender_Selection_Cycles\"><\/span>PGD Cinsiyet Se\u00e7imi D\u00f6ng\u00fclerinde Ba\u015far\u0131 Oranlar\u0131<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GynoLife IVF Merkezi'ndeki PGD (Preimplantasyon Genetik Tan\u0131) cinsiyet belirleme uygulamalar\u0131, \u00fcst\u00fcn ba\u015far\u0131 oranlar\u0131 elde etmektedir. \u00c7\u00fcnk\u00fc transfer i\u00e7in yaln\u0131zca kromozomal olarak normal embriyolar se\u00e7ildi\u011finden, genetik tan\u0131 uygulanmayan standart IVF'e k\u0131yasla transfer ba\u015f\u0131na d\u00fc\u015fen implantasyon oran\u0131 artmaktad\u0131r. 35 ya\u015f alt\u0131 hastalar i\u00e7in, PGD ile test edilmi\u015f embriyolarla yap\u0131lan transfer ba\u015f\u0131na gebelik oranlar\u0131 tipik olarak y\u00fczde 65'in \u00fczerindedir. Daha ileri ya\u015f gruplar\u0131ndaki hastalar i\u00e7in bile, kromozomal olarak normal embriyolar\u0131n se\u00e7ilmesi, ba\u015far\u0131l\u0131 bir sonu\u00e7 elde etme \u015fans\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131rmaktad\u0131r.<\/p>\n<p>Se\u00e7im i\u00e7in mevcut embriyo say\u0131s\u0131n\u0131n, toplanan ve d\u00f6llenen yumurta say\u0131s\u0131n\u0131n yan\u0131 s\u0131ra blastokist a\u015famas\u0131na ula\u015fan ve kromozomal olarak normal olan embriyo oran\u0131na ba\u011fl\u0131 oldu\u011funu belirtmek \u00f6nemlidir. T\u00fcm embriyolar istenen cinsiyette olmayacak ve t\u00fcm\u00fc kromozomal olarak normal olmayacakt\u0131r. GynoLife'taki uzman\u0131n\u0131z, dan\u0131\u015fmanl\u0131\u011f\u0131n\u0131z s\u0131ras\u0131nda bireysel ko\u015fullar\u0131n\u0131za g\u00f6re ger\u00e7ek\u00e7i beklentileri tart\u0131\u015facakt\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Ethical_Considerations\"><\/span>Etik Hususlar<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Cinsiyet se\u00e7imi g\u00fc\u00e7l\u00fc g\u00f6r\u00fc\u015fleri tetikleyen bir konudur ve hastalar\u0131n bu karar\u0131n etik boyutlar\u0131n\u0131 g\u00f6z \u00f6n\u00fcnde bulundurmalar\u0131 \u00f6nemlidir. GynoLife IVF Merkezi olarak, etik t\u0131bbi uygulamalara olan ba\u011fl\u0131l\u0131\u011f\u0131m\u0131z\u0131 s\u00fcrd\u00fcr\u00fcrken cinsiyet se\u00e7imine hastan\u0131n \u00f6zerkli\u011fine sayg\u0131 duyarak yakla\u015f\u0131yoruz.<\/p>\n<p>Aile planlamas\u0131n\u0131n, tam bilgi sahibi hastalar taraf\u0131ndan, t\u0131bbi ekipleriyle isti\u015fare ederek al\u0131nmas\u0131 gereken ki\u015fisel bir karar oldu\u011funa inan\u0131yoruz. Rol\u00fcm\u00fcz, her hastan\u0131n kendi aile planlamas\u0131 hakk\u0131nda karar verme hakk\u0131na sayg\u0131 duyarken do\u011fru bilgi, uzman t\u0131bbi bak\u0131m ve destekleyici rehberlik sa\u011flamakt\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_International_Patients_Should_Prepare\"><\/span>Uluslararas\u0131 Hastalar\u0131n Haz\u0131rlamas\u0131 Gerekenler<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>E\u011fer cinsiyet se\u00e7imi i\u00e7in PGD'yi d\u00fc\u015f\u00fcnen uluslararas\u0131 bir hasta iseniz, GynoLife IVF Merkezi'nde tedavi yolculu\u011funuz i\u00e7in haz\u0131rlaman\u0131z gerekenler a\u015fa\u011f\u0131dad\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Initial_Consultation\"><\/span>\u0130lk Dan\u0131\u015fma<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Yolculu\u011funuz, g\u00f6r\u00fcnt\u00fcl\u00fc g\u00f6r\u00fc\u015fme yoluyla ger\u00e7ekle\u015ftirilebilen ayr\u0131nt\u0131l\u0131 bir dan\u0131\u015fmanl\u0131k ile ba\u015flar. Bu dan\u0131\u015fmanl\u0131k s\u0131ras\u0131nda uzman\u0131n\u0131z t\u0131bbi ge\u00e7mi\u015finizi g\u00f6zden ge\u00e7irecek, hedeflerinizi tart\u0131\u015facak ve tedaviye ba\u015flamadan \u00f6nce tamamlanmas\u0131 gereken \u00f6n haz\u0131rl\u0131k testlerini \u00f6nerecektir.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Treatment_Timeline\"><\/span>Tedavi Zaman \u00c7izelgesi<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Bir PGD cinsiyet se\u00e7imi d\u00f6ng\u00fcs\u00fc genellikle K\u0131br\u0131s'a iki seyahat veya tek bir uzun konaklama gerektirir. \u0130lk ziyaret, yakla\u015f\u0131k 10 ila 14 g\u00fcn s\u00fcren IVF uyar\u0131m\u0131n\u0131 ve yumurta toplama a\u015famas\u0131n\u0131 kapsar. Embriyo biyopsisi ve genetik testin bir ila iki hafta s\u00fcrmesinin ard\u0131ndan, embriyo dondurma ve transferi i\u00e7in geri d\u00f6nersiniz, bu da K\u0131br\u0131s'ta yakla\u015f\u0131k \u00fc\u00e7 ila be\u015f g\u00fcn gerektirir. Alternatif olarak, baz\u0131 hastalar uyar\u0131m a\u015famas\u0131n\u0131 uzaktan y\u00f6netmeyi ve yumurta toplama i\u00e7in tek bir seyahat yapmay\u0131 tercih eder, transfer daha sonraki bir ziyaret i\u00e7in planlan\u0131r.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Required_Documents_and_Tests\"><\/span>Gerekli Belgeler ve Testler<span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Uluslararas\u0131 hastalar, uzmanlar\u0131n\u0131n istedi\u011fi g\u00fcncel kan tahlili, hormonal de\u011ferlendirme ve ultrason sonu\u00e7lar\u0131n\u0131 haz\u0131rlamal\u0131d\u0131r. Tedaviden \u00e7ok \u00f6nce ge\u00e7erli pasaport ve gerekli vize belgeleri ayarlanmal\u0131d\u0131r.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Combining_PGD_with_Other_Services\"><\/span>PGD'yi Di\u011fer Hizmetlerle Birle\u015ftirmek<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>PGD cinsiyet se\u00e7imi GynoLife T\u00fcp Bebek Merkezi'nde sunulan di\u011fer tedavilerle birle\u015ftirilebilir. Yumurta don\u00f6r\u00fcne ihtiya\u00e7 duyan hastalar i\u00e7in veya <a href=\"\/tr\/hizmet\/sperm-donasyonu-ile-tup-bebek-tedavisi\/\">ba\u011f\u0131\u015f sperm<\/a>, PGD, sperm don\u00f6rlerinden elde edilen embriyolara da uygulanabilir. Hastalar PGD'yi ayr\u0131ca \u015funlarla da birle\u015ftirebilir <a href=\"\/tr\/hizmet\/embriyo-dondurma-kriyoprezervasyon\/\">embriyo dondurma<\/a> gelecekte aile planlamas\u0131 i\u00e7in her iki cinsiyette genetik olarak test edilmi\u015f embriyolar\u0131 saklamak. Yumurta verimini en \u00fcst d\u00fczeye \u00e7\u0131karmak isteyen hastalar i\u00e7in, <a href=\"\/tr\/hizmet\/tandem-ivf-tedavi-cift-uyari-2\/\">tandem IVF (\u00e7ift stim\u00fclasyon)<\/a> PGD testinden \u00f6nce yap\u0131labilir.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Begin_Your_Family_Balancing_Journey\"><\/span>Aile Denge Yolculu\u011funuza Ba\u015flay\u0131n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>K\u0131br\u0131s'taki GynoLife IVF Merkezi'nde sunulan cinsiyet se\u00e7imi i\u00e7in PGD, uluslararas\u0131 hastalara \u00e7ocuklar\u0131n\u0131n cinsiyetini se\u00e7meleri i\u00e7in g\u00fcvenli, yasal ve son derece etkili bir yol sunar. Neredeyse kusursuz do\u011fruluk, kapsaml\u0131 genetik tarama ve deneyimli bir t\u0131bbi ekibin deste\u011fi ile aile planlama hedeflerinize g\u00fcvenle ula\u015fabilirsiniz.<\/p>\n<p>Hayal etti\u011finiz aile planlamas\u0131nda size nas\u0131l yard\u0131mc\u0131 olabilece\u011fimizi ve PGD cinsiyet se\u00e7imi hakk\u0131nda daha fazla bilgi edinmek i\u00e7in bug\u00fcn bizimle ileti\u015fime ge\u00e7in.<\/p>\n<p><strong><a href=\"\/tr\/randevu-2\/\">Doktor G\u00f6r\u00fc\u015fmesi Talep Et<\/a><\/strong> GynoLife T\u00fcp Bebek Merkezi ile aile dengenize do\u011fru ilk ad\u0131m\u0131 at\u0131n.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cinsiyet Se\u00e7imi i\u00e7in PGD'yi Anlamak Preimplantasyon Genetik Tan\u0131 (PGD), bir IVF d\u00f6ng\u00fcs\u00fc s\u0131ras\u0131nda embriyolar\u0131n rahme transfer edilmeden \u00f6nce genetik olarak test edilmesini sa\u011flayan geli\u015fmi\u015f bir \u00fcreme teknolojisidir. PGD ba\u015flang\u0131\u00e7ta ciddi genetik hastal\u0131klar\u0131 taramak i\u00e7in geli\u015ftirilmi\u015f olsa da, embriyo cinsiyetinin de neredeyse kusursuz bir do\u011frulukla belirlenmesini sa\u011flar. <\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[58,93],"tags":[],"class_list":["post-5215","post","type-post","status-publish","format-standard","hentry","category-ivf-in-vitro-fertilization","category-ivfmag"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/posts\/5215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/comments?post=5215"}],"version-history":[{"count":0,"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/posts\/5215\/revisions"}],"wp:attachment":[{"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/media?parent=5215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/categories?post=5215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gynolifeivf.com\/tr\/wp-json\/wp\/v2\/tags?post=5215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}